Ibex Medical Analytics, which develops AI-powered clinical-grade solutions that help pathologists detect and grade cancer in biopsies, announced a $38 million Series B financing round.
Ibex Medical Analytics, which develops AI-powered clinical-grade solutions that help pathologists detect and grade cancer in biopsies, announced a $38 million Series B financing round.